Pilot study to estimate the effectiveness and safety of the New TB Novel Regimen treatment in the Philippines.
On February 8–10, 2023, in Brentwood Suites Hotel, Quezon City, The Lung Center of the Philippines – Project Management Office, Research Unit, in collaboration with the DOH Disease Prevention and Control Bureau (DOH-DPCB), Philippine Business for Social Progress (PBSP), Advancing Client-centered Care and Expanding Sustainable Services for TB (ACCESS TB Project) Project and Tropical Disease Foundation Inc. (TDFI) conducted a Research Implementation Review for the following study: Pilot study to estimate the effectiveness and safety of the BPaL treatment regimen in the Philippines. A committed group of researchers under the direction of Dr. Irene Flores served as the project’s principal investigator, while Dr. Mamel Quelapio, a LIFT-TB consultant, provided technical direction. Twelve OR sites from ten different regions which are the following: Lung Center of the Philippines PMDT TC in Quezon City, Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium PMDT TC in Caloocan city, Ilocos Training and Regional Medical Center in La Union, Jose B. Lingad Memorial Regional Hospital in Pampanga, Batangas Medical Center in Batangas City, Sorsogon Medical Mission Group Hospital & Health Services Cooperative in Sorsogon City, Western Visayas Medical Center in Iloilo City, Eversly Child Sanitarium in Mandaue City Cebu, Zamboanga City Medical Center in Zamboanga City, Xavier University Community Health Care Center in Cagayan De Oro City, Region I Medical Center Dagupan City in Dagupan City Pangasinan and Southern Philippines Medical Center – Official in Davao City.
Given the goals of the PIR and Workshop, they respect our participation as an NTP partner and have extended an invitation to TBpeople Philippines Organization Inc. to participate in this important activity. TBpeoplePH emphasized the importance of CBOs on the health program more now that we are now on the re-devolvement of services and the need to uptake of the new novel regimen BPaLM.This participation is supported by Stop TB Partnership Challenge Facility for Civil Society (CFCS). #TBpeoplePH#TBFreePH#BPaL#BPaLM#DOH#DPCB#ACCESSTB#TDFI#PIR#PBSP#TBAlliance#EndTB#TibayNgBayanihangPinoy#StopTB